Jacobs Levy Equity Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-463,593
| Closed | -$1.06M | – | 1077 |
|
|
2024
Q2 | $1.06M | Buy |
463,593
+85,735
| +23% | +$195K | ﹤0.01% | 730 |
|
|
2024
Q1 | $1.63M | Buy |
377,858
+64,790
| +21% | +$280K | 0.01% | 630 |
|
|
2023
Q4 | $955K | Sell |
313,068
-260,188
| -45% | -$794K | ﹤0.01% | 729 |
|
|
2023
Q3 | $825K | Buy |
573,256
+80,480
| +16% | +$116K | ﹤0.01% | 705 |
|
|
2023
Q2 | $1.23M | Buy |
492,776
+209,541
| +74% | +$522K | 0.01% | 661 |
|
|
2023
Q1 | $759K | Buy |
283,235
+190,189
| +204% | +$510K | ﹤0.01% | 746 |
|
|
2022
Q4 | $505K | Sell |
93,046
-9,472
| -9% | -$51.4K | ﹤0.01% | 791 |
|
|
2022
Q3 | $1.28M | Sell |
102,518
-303,546
| -75% | -$3.79M | 0.01% | 658 |
|
|
2022
Q2 | $2.01M | Buy |
+406,064
| New | +$2.01M | 0.02% | 598 |
|
|
2021
Q3 | – | Sell |
-10,989
| Closed | -$241K | – | 1137 |
|
|
2021
Q2 | $241K | Sell |
10,989
-28,297
| -72% | -$621K | ﹤0.01% | 958 |
|
|
2021
Q1 | $945K | Sell |
39,286
-88,797
| -69% | -$2.14M | 0.01% | 746 |
|
|
2020
Q4 | $2.3M | Buy |
128,083
+4,784
| +4% | +$86.1K | 0.02% | 551 |
|
|
2020
Q3 | $1.42M | Buy |
123,299
+67,041
| +119% | +$774K | 0.01% | 587 |
|
|
2020
Q2 | $1.37M | Buy |
56,258
+23,070
| +70% | +$560K | 0.01% | 602 |
|
|
2020
Q1 | $366K | Buy |
33,188
+23,761
| +252% | +$262K | ﹤0.01% | 801 |
|
|
2019
Q4 | $249K | Buy |
+9,427
| New | +$249K | ﹤0.01% | 903 |
|